On Demand: HeartX Webinar Series: Emerging Innovation in CV Diagnostics, Monitoring and Clinical Decision Support-Webinar Slides

Webinar Slides

Pdf Summary

This document is a compilation of multiple cardiovascular technology presentations focused on improving diagnosis, monitoring, and specialty care delivery through AI, robotics, and wearable sensing.<br /><br />The first section highlights Dopl Technologies, which aims to expand access to ultrasound and specialist care through remote robotic and autonomous workflows. It frames the healthcare problem as one of staffing shortages, rural hospital financial strain, fragmented care, and lost imaging revenue. Dopl’s Traverse platform is presented as a remote robotic ultrasound solution that can reduce wait times, retain patients in-community, and create new revenue for hospitals with minimal capital and staffing burden. The company positions itself as starting with imaging and expanding into other specialties and procedural care.<br /><br />The second section introduces Echopoint Medical’s iKOr device, designed to simplify coronary physiology testing for patients with ANOCA/INOCA and CMD. It argues that many patients with angina have no obstructive disease on angiography but still need fuller physiology assessment. iKOr is described as a saline-free, single-pass microcatheter that measures FFR, CFR, and IMR over an existing guidewire, with future expansion into vasospasm and endothelial testing. The company emphasizes workflow simplicity, clinical adoption, and planned FDA pathways.<br /><br />The third section presents HEARTio, an AI-based ECG diagnostic platform intended to detect anatomic coronary artery disease earlier and noninvasively. It claims ECG plus AI can identify CAD before invasive testing, reduce unnecessary procedures, and create a major market opportunity. The company discusses validation studies, FDA strategy, customer interest, and a broader roadmap to additional cardiac diagnostics.<br /><br />The final section features LiveMetric, a wearable, passive blood pressure and hemodynamic monitoring platform. It emphasizes continuous, calibration-free monitoring, FDA/CE clearance, AI-driven waveform analysis, and reimbursement pathways for remote patient monitoring and self-measured blood pressure programs. Overall, the document showcases a shared theme: using technology to shift cardiovascular care toward earlier detection, remote delivery, and more efficient, data-driven management.

Keywords

cardiovascular technology

remote robotic ultrasound

coronary physiology testing

AI ECG diagnostics

wearable blood pressure monitoring

ANOCA INOCA CMD

remote patient monitoring

anatomic coronary artery disease

FDA clearance

specialty care delivery